Phil Grayson

Phil Grayson is a Senior Scientist at Beam Therapeutics, a position held since May 2022, following a role as Scientist II. Prior experience includes serving as a Bioinformatics Scientist - Biologist at Harvard Medical School from February 2021 to May 2022 and as a Postdoctoral Fellow at the University of Manitoba from September 2019 to January 2021. Phil Grayson earned a Doctor of Philosophy (Ph.D.) in Evolutionary Biology with a focus on Genomics and Developmental Biology from Harvard University, completed in May 2019. Prior educational achievements include a Master's Degree in Bioscience, Technology, and Public Policy from The University of Winnipeg and a Bachelor of Science (Honors) in Biology from the same institution.